Yatharth Hospital & Trauma Care Services Ltd

Q4 FY25Healthcare Services

Yatharth Hospital & Trauma Care Services Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹855

Market cap₹8.3K Cr

P/E47.2

Updated23 Aug 2026

Read5 min read

The short version

The company has maintained a strong growth trajectory, with a consistent ~30% year-on-year revenue growth over the past few years. The company has demonstrated a consistent 30% year-on-year growth in revenue over the past few years and expects to sustain this momentum going forward.

From Yatharth Hospital & Trauma Care Services Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

The company has maintained a strong growth trajectory, with a consistent ~30% year-on-year revenue growth over the past few years.
Confident about sustaining this growth momentum in revenue and profitability for FY '26 and beyond.
Expect continued volume growth: inpatient volume up 34%, outpatient volume up 16% YoY in FY '25.
New hospitals like Delhi and Faridabad are expected to perform similarly to Greater Faridabad hospital, contributing positively.
Specialty segments, especially super-specialties like oncology, neurosurgery, and cardiac surgery, are growing faster and expected to contribute 60-70% revenue per hospital.
ARPOB (average revenue per occupied bed) is increasing by more than 10% year-on-year.

2 more points management made on revenue & sales performance

Profitability & Margins

The company has demonstrated a consistent 30% year-on-year growth in revenue over the past few years and expects to sustain this momentum going forward.
EBITDA margins are anticipated to stabilize around Q4 FY '25 levels, with only minor fluctuations of ±0.5%.
New hospitals (Delhi and Faridabad) are expected to become EBITDA breakeven within 12-15 months from operationalization, supporting future margin improvement.
Net profit grew 14% Y-o-Y in FY '25, with continued profitability growth expected.
Working capital improvement and receivable days reduction over 2-3 years should enhance cash flow and earnings quality.

2 more points management made on profitability & margins

See what Yatharth Hospital & Trauma Care Services Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Planned capex of around INR 300 crores for the current and next financial year, focused on existing 7 hospitals including New Delhi and Faridabad facilities.
Major investments include:
INR 100 crores for the 400-bedded Faridabad hospital for medical equipment and construction.
Around INR 55 crores for medical equipment at the New Delhi hospital.
Remaining capex allocated to Noida Extension, Greater Noida, Greater Faridabad, and brownfield expansions.
Capex per bed estimated at INR 7-8 million for existing hospitals.
Additional separate capex planned for inorganic acquisitions or new greenfield projects.
Intention to add at least one new hospital facility during the financial year.

2 more points management made on capital expenditure plans

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential

1Health X Platform₹919 Cr

Rev 1Mar 1

2Chandan Healthca₹590 Cr

Rev 1Mar 3

3₹66.2K Cr

Rev 2Mar 1

4₹1.8K Cr

Rev 2Mar 2

5₹649 Cr

Rev 2Mar 2

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

There was a Qualified Institutional Placement (QIP) in December 2024, which added INR 6,145 million as security premium to reserves as a one-time event.
No explicit mention of a new equity fundraising planned immediately, but any new inorganic acquisitions or greenfield projects would require separate capex and potentially additional funding.
Promoters have pledged 8% of shares to raise INR 130 crores for personal investments, unrelated to the company’s funding needs.
The company plans capex of around INR 300 crores per year for the next 2-3 years for existing hospitals and expansions; inorganic acquisitions will require additional capital.

2 more points management made on fundraising & capital structure

See what Yatharth Hospital & Trauma Care Services Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders for Yatharth Hospitals and Trauma Care Services Limited. However, relevant points related to expansions and acquisitions include: - The company plans to add at least 1 new facility in the current financial year, with more clarity expected in coming quarters. - Capex guidance includes around INR 300 crores over the next 2-3 years on existing hospitals, including new hospitals in New Delhi and Faridabad.

- Additional inorganic acquisitions or greenfield projects will require separate capex, with acquisition costs estimated around INR 80 lakhs to INR 1 crore excluding land. - Growth and capacity additions suggest ongoing and future project pipeline but specific order book or pending orders details are not disclosed. If you need details on specific contracts or order inflow, the transcript does not provide this information.

2 more points management made on order book & pipeline

Yatharth Hospital & Trauma Care Services Ltd — Quarterly revenue & net profit

Revenue Net profit

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹342 Cr, net profit ₹45 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Yatharth Hospit.'s management said in earlier quarters

Others in Healthcare Services this season

3B Blackbio DX Ltd (Q4 FY25)
UK subsidiary (TRUPCR Europe Limited) revenue FY 2024-25: GBP 1,287,580, a 94% increase over FY 2023-24 GBP 664,059. Key concall takeaways from 3B Blackbio DX…
Apollo Hospitals Enterprise Ltd (Q4 FY25)
. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.
Shalby (Q4 FY25)
Implant business is in high-growth mode: 4x growth in Indonesia, 35-40% growth in U.S., and 2.5x growth in India reported last year. Key concall takeaways from…
Suraksha Diagno. (Q4 FY25)
Volume of tests conducted has been growing at around 10% year-on-year between FY '24 and FY '25. Key concall takeaways from Suraksha Diagnostic Ltd's Q4 FY25…

Compare:vs Apollo Hospitals Enterprise Ltd vs Max Healthcare vs Manipal Health

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Yatharth Hospital & Trauma Care Services Ltd Q4 FY25 results?

What is Yatharth Hospital & Trauma Care Services Ltd share price analysis?

Yatharth Hospital & Trauma Care Services Ltd currently shows a neutral. The stock trades at a P/E of 47.2 with a market cap of ₹8,271 Cr. Investors should review the full earnings analysis for detailed insights.

Is Yatharth Hospital & Trauma Care Services Ltd planning capital expenditure?

Planned capex of around INR 300 crores for the current and next financial year, focused on existing 7 hospitals including New Delhi and Faridabad facilities.

Keep Yatharth Hospital & Trauma Care Services Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.